Updated Risk Assessment of Cannabidiol in Foods Based on Benchmark Dose–Response Modeling
Abstract Cannabidiol (CBD), a non-psychotropic main component of the Cannabis plant, has been approved as a drug in the European…
Stephan G. Walch
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Abstract Cannabidiol (CBD)-containing products are widely marketed as over the counter products. Adverse effects reported in anecdotal consumer reports or…
Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke
Abstract Introduction: Recent research claimed that CBD in commercial electronic cigarette (e-cigarette) liquids can be converted into psychotropic amounts of…
Time Trends of Tetrahydrocannabinol (THC) in a 2008–2021 German National Survey of Hemp Food Products
Abstract ∆9-Tetrahydrocannabinol (THC) is known as the main psychotropic compound present in the hemp plant. It also occurs in commercially…